Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

NCT04447547 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hodgkin's Lymphoma

Interventions

BIOLOGICAL: CD19 CAR-T

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.

Collaborators

[object Object]
[object Object]